4.7 Article

Unraveling the role of Epac1-SOCS3 signaling in the development of neonatal-CRD-induced visceral hypersensitivity in rats

期刊

CNS NEUROSCIENCE & THERAPEUTICS
卷 28, 期 9, 页码 1393-1408

出版社

WILEY
DOI: 10.1111/cns.13880

关键词

corticotrophin-releasing factor; Epac1; neonatal colorectal distension; SOCS3; visceral hypersensitivity

资金

  1. National Natural Science Foundation of China [82071228, 81771203, 81772065]
  2. Key Subject of Colleges and Universities Natural Science Foundation of Jiangsu Province [19KJA 110001]
  3. Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18-2195]
  4. Jiangsu college students' innovation and entrepreneurship training program [202010313001Z]

向作者/读者索取更多资源

The Epac1-SOCS3 signaling pathway plays a significant role in visceral hypersensitivity. In this study, changes in the expression of Epac1 and SOCS3, as well as elevated levels of IL-6, were observed in a neonatal colorectal distension-induced visceral hypersensitivity model. Interventions targeting Epac1, SOCS3, or IL-6 were found to alleviate the symptoms of visceral hypersensitivity.
Aims Visceral hypersensitivity in irritable bowel syndrome (IBS) is widespread, but effective therapies for it remain elusive. As a canonical anti-inflammatory protein, suppressor of cytokine signaling 3 (SOCS3) reportedly relays exchange protein 1 directly activated by cAMP (Epac1) signaling and inhibits the intracellular response to inflammatory cytokines. Despite the inhibitory effect of SOCS3 on the pro-inflammatory response and neuroinflammation in PVN, the systematic investigation of Epac1-SOCS3 signaling involved in visceral hypersensitivity remains unknown. This study aimed to explore Epac1-SOCS3 signaling in the activity of hypothalamic paraventricular nucleus (PVN) corticotropin-releasing factor (CRF) neurons and visceral hypersensitivity in adult rats experiencing neonatal colorectal distension (CRD). Methods Rats were subjected to neonatal CRD to simulate visceral hypersensitivity to investigate the effect of Epac1-SOCS3 signaling on PVN CRF neurons. The expression and activity of Epac1 and SOCS3 in nociceptive hypersensitivity were determined by western blot, RT-PCR, immunofluorescence, radioimmunoassay, electrophysiology, and pharmacology. Results In neonatal-CRD-induced visceral hypersensitivity model, Epac1 and SOCS3 expressions were downregulated and IL-6 levels elevated in PVN. However, infusion of Epac agonist 8-pCPT in PVN reduced CRF neuronal firing rates, and overexpression of SOCS3 in PVN by AAV-SOCS3 inhibited the activation of PVN neurons, reduced visceral hypersensitivity, and precluded pain precipitation. Intervention with IL-6 neutralizing antibody also alleviated the visceral hypersensitivity. In naive rats, Epac antagonist ESI-09 in PVN increased CRF neuronal firing. Consistently, genetic knockdown of Epac1 or SOCS3 in PVN potentiated the firing rate of CRF neurons, functionality of HPA axis, and sensitivity of visceral nociception. Moreover, pharmacological intervention with exogenous IL-6 into PVN simulated the visceral hypersensitivity. Conclusions Inactivation of Epac1-SOCS3 pathway contributed to the neuroinflammation accompanied by the sensitization of CRF neurons in PVN, precipitating visceral hypersensitivity and pain in rats experiencing neonatal CRD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据